bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report)’s stock price dropped 7.1% during trading on Wednesday . The company traded as low as $0.92 and last traded at $0.92. Approximately 175 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 4,907 shares. The stock had previously closed at $0.99.
bioAffinity Technologies Price Performance
The stock’s 50 day moving average price is $1.16 and its two-hundred day moving average price is $0.79.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Read More
- Five stocks we like better than bioAffinity Technologies
- What is a Secondary Public Offering? What Investors Need to Know
- What a Trump Win Looks Like for the Market Now and Into 2025
- Upcoming IPO Stock Lockup Period, Explained
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Why Are Stock Sectors Important to Successful Investing?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
